Results 1 - 20 of 115 in Cephalon
-
Cephalon sues Barr Pharmaceuticals
Cephalon Inc. said Thursday night it filed a patent infringement lawsuit earlier this week against Barr Pharmaceuticals Inc.
Comment?
-
Barr Confirms Patent Challenge of Fentora Tablets
Barr Pharmaceuticals, Inc. today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Cephalon, Inc.
Comment?
-
Health Winners & Losers: Genentech
... big biotech stocks got a lift on the M&A news. Genentech peer Biogen Idec BIIB gained 3.4%, and Celgene CELG , Cephalon CEPH and Genzyme GENZ tacked on 0.9%, 1.4% and 2%, respectively. The Amex biotechnology index added 2% to 811.15. The Amex pharma ...
Comment?
-
Cramer on BloggingStocks: Genentech bid confirms the trend
... group is running, including Biogen (NASDAQ: BIIB ) ( Cramer's Take ), as the B section of the Journal shows, and Cephalon (NASDAQ: CEPH ) ( Cramer's Take ), which seems like nothing but net lately. Finally, there is the sentiment issue. Every time ...
Comment?
-
... Inc. will be protected by a patent for the next 16 years. Business Courier of Cincinnati on January 24, 2008 Cephalon: Feds want more information on generic deals Cephalon Inc. said Friday it received a subpoena Wednesday from the Federal Trade ...
Comment?
-
Zacks Bull and Bear of the Day Highlights: Canadian Solar, Corp....
... EXBD) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on UDR, Inc. (NYSE: UDR), Cephalon, Inc. (Nasdaq: CEPH) and ASML Holding N.V. (Nasdaq: ASML ). Full analysis of all these stocks is available at ...
Comment?
-
Zacks Bull and Bear of the Day Highlights: Canadian Solar, Corp....
... EXBD) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on UDR, Inc. (NYSE: UDR), Cephalon, Inc. (Nasdaq: CEPH) and ASML Holding N.V. (Nasdaq: ASML ). Full analysis of all these stocks is available at ...
Comment?
-
The settlement of all patent infringement cases on Provigil has been a significant positive for Cephalon, Inc.
Comment?
-
Acusphere warned of Nasdaq delisting
... In March, Acusphere licensed its drug-delivery technology for the treatment of cancer to biopharmaceutical company Cephalon Inc. for $10 million cash. The license to Cephalon, which is based in Frazer, Pa., includes rights to its formulation of ...
Comment?
-
Pfizer Looking at a Level Playing Field
... advisory panel said that the FDA's worries about epilepsy drugs, like GlaxoSmithKline 's (NYSE: GSK ) Lamictal and Cephalon 's (Nasdaq: CEPH ) Gabitril, are much ado about nothing. Or, more precisely, much ado about a little. Those on the committee ...
Comment?
-
Biotech Earnings: Second-Quarter Preview
... to some on Wall Street. But its peers aren't exactly blending into the background. Prescription data suggest Amgen, Cephalon CEPH and Celgene could deliver better-than-expected product sales. "Overall, we think that 2Q earnings season could be quite ...
Comment?
-
Binswanger marketing pharma plantBy Sam Black
Cephalon Inc. has hired Binswanger Corp. to sell or lease the Cima Labs pharmaceutical plant in Eden Prairie, even though it won't be available for a few years.
Comment?
-
... ensure advancement, relevancy and timeliness of information and is funded by an independent educational grant from Cephalon, Inc. ESP has also recently received national recognition for the fourth year in a row for the quality of health information ...
Comment?
-
University presidents weigh their civic role
... as opposed to our being the leadership." Barchi gets enthusiastic describing work with corporate leaders such as Cephalon CEO Frank Baldino on relocation and job-promotion efforts such as BioAdvance. "The Delaware Valley has made huge strides in ...
Comment?
-
Cephalon Quarterly Conference Call Invitation
Second Quarter 2008 Earnings Conference Call Tuesday, July 29, 2008, 5:00 p.m. U.S. EDT FRAZER, Pa., June 26 /PRNewswire-FirstCall/ -- Cephalon, Inc.
Comment?
-
Cephalon Gets Push From Patent
Cephalon By JMP Securities WITH CEPHALON'S recently extended patent protection for AMRIX [pain reliever], as well as our diligence on Treanda [for indolent, or slowly progressing, non-Hodgkin's lymphoma ] use ...
Comment?
-
... its debt load does not look excessive relative to the burdens that competitors such as Shire (Nasdaq: SHPGY ) and Cephalon (Nasdaq: CEPH ) bear, Cyberonics has one issue that those two do not: negative free cash flow . Although that negativity has ...
Comment?
-
Doctors may soon prescribe addictive drugs online
... disorder drugs like Shire Pharmaceuticals (nasdaq: SHPGY - news - people )' Adderall and painkillers like Cephalon Inc. (nasdaq: CEPH - news - people )'s Fentora. The concern is that patients are more likely to abuse these treatments, and their ...
Comment?
-
Alkermes (ALKS): Price cycles in bullish 'pennant' consolidation pattern
The firm developed and manufactures Vivitrol, a treatment for alcohol dependence that partner Cephalon markets in the United States.
Comment?
-
OATSystems Selected for RFID Implementation
Cephalon, Inc. has selected OATSystems' RFID solution for serialized shipment container tracking, extending its SAP Auto-ID Infrastructure for RFID reach to operational processes and workflows.
Comment?
Cephalon Forum
Most Popular
